Eliem Therapeutics, Inc.

NasdaqGM:ELYM Stock Report

Mkt Cap: US$102.3m

Eliem Therapeutics Company Information

Eliem Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Eliem Therapeutics, Inc.
  • Ticker: ELYM
  • Exchange: NasdaqGM
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$102.286m
  • Shares outstanding: 26.57m
  • Website: https://www.eliemtx.com

Number of Employees


  • Eliem Therapeutics, Inc.
  • 23515 NE Novelty Hill Road
  • Suite B221 #125
  • Redmond
  • Washington
  • 98053
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ELYMNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDAug 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/29 00:00
End of Day Share Price2023/01/26 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.